Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Jackson

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Ebiomedicine|December 6, 2020
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret modelPamela C Proud, Daphne Tsitoura, Robert J Watson, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
Nature Immunology|February 20, 2019
Human CD8<sup>+</sup> T cell cross-reactivity across influenza A, B and C virusesMarios Koutsakos, Patricia T Illing, Thi H O Nguyen, et al.
Nature Communications|May 19, 2021
CD8<sup>+</sup> T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorphLuca Hensen, Patricia T Illing, E Bridie Clemens, et al.
Ebiomedicine|May 6, 2023
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccineGeorgia Deliyannis, Nicholas A Gherardin, Chinn Yi Wong, et al.
Ebiomedicine|November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose boosterTerry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
Nature Communications|April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderlyKevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Cell Reports. Medicine|February 10, 2021
Integrated immune dynamics define correlates of COVID-19 severity and antibody responsesMarios Koutsakos, Louise C Rowntree, Luca Hensen, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Ebiomedicine|December 6, 2020
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret modelPamela C Proud, Daphne Tsitoura, Robert J Watson, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
Nature Immunology|February 20, 2019
Human CD8<sup>+</sup> T cell cross-reactivity across influenza A, B and C virusesMarios Koutsakos, Patricia T Illing, Thi H O Nguyen, et al.
Nature Communications|May 19, 2021
CD8<sup>+</sup> T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorphLuca Hensen, Patricia T Illing, E Bridie Clemens, et al.
Ebiomedicine|May 6, 2023
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccineGeorgia Deliyannis, Nicholas A Gherardin, Chinn Yi Wong, et al.
Ebiomedicine|November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose boosterTerry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
Nature Communications|April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderlyKevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Cell Reports. Medicine|February 10, 2021
Integrated immune dynamics define correlates of COVID-19 severity and antibody responsesMarios Koutsakos, Louise C Rowntree, Luca Hensen, et al.
Pageof 12